Industries: Biotech & Pharma, eHealth
Funding stage: Series A (1 M EUR - < 5 M EUR) Founded: 2011 Employees: From 6 to 10
Business model: - Target: Business
Technological platform for developing new drugs with own products for treating schizophrenia, epilepsy and cancer in children.
Minority stake unknown %
Investors: CAIXA CAPITAL RISC, KINLED HOLDING LTD, ASCIL PROYECTOS SL, EMPRESA NACIONAL DE INNOVACION SA
Investors: UNDISCLOSED PRIVATE INVESTORS
Source: Press releases , newsletters & platforms , company websites , annual reports & accounts , regulatory body sites & stock exchanges
We are continually updating our list of new startups so please let us know if you have recently started one.